Trevena Announces Wake Forest Baptist Health Joining OLINVYK Clinical Outcomes Study
CHESTERBROOK, PA — Trevena, Inc. (Nasdaq: TRVN) announced Wake Forest Baptist Health Medical Center will join the VOLITION (“Intravenous Oliceridine and Opioid Related Complications”) study which examines the impact of OLINVYK (oliceridine) …
Trevena Announces Wake Forest Baptist Health Joining OLINVYK Clinical Outcomes Study Read More